Bruno Geloneze
Bruno Geloneze is a prominent endocrinologist and the principal researcher at the Obesity and Comorbidities Research Center (OCRC) at the State University of Campinas (Unicamp), known for his expertise in obesity treatment and his evaluation of the comparative efficacy and safety of medications like tirzepatida and semaglutida.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Liechtenstein:
Bruno Geloneze is the principal researcher at the Center for Research in Obesity and Comorbidities.
7
Liechtenstein:
Bruno Geloneze is the principal researcher at the Center for Research in Obesity and Comorbidities at the University of Campinas and discusses the complexities of weight loss promotion.
7